{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:21:02Z","timestamp":1761708062434},"publisher-location":"Chichester, UK","reference-count":62,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006320.pub2","type":"reference-entry","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T19:45:17Z","timestamp":1175629517000},"source":"Crossref","is-referenced-by-count":24,"title":["Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease"],"prefix":"10.1002","author":[{"given":"D","family":"Turner","sequence":"first","affiliation":[]},{"given":"SH","family":"Zlotkin","sequence":"additional","affiliation":[]},{"given":"PS","family":"Shah","sequence":"additional","affiliation":[]},{"given":"AM","family":"Griffiths","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2007,4,18]]},"reference":[{"issue":"24","key":"10.1002\/14651858.CD006320.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199606133342401","article-title":"Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease","volume":"334","author":"Belluzzi","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1002\/14651858.CD006320.pub2-BIB2|cit2","first-page":"A930","article-title":"A new enteric coated preparation of omega-3 fatty acids for preventing post-surgical recurrence in Crohn's disease","volume":"112","author":"Belluzzi","year":"1997","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD006320.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3109\/00365529609010352","article-title":"Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group)","volume":"31","author":"Lorenz-Meyer","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"45","key":"10.1002\/14651858.CD006320.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.3748\/wjg.v11.i45.7118","article-title":"Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study","volume":"11","author":"Romano","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1002\/14651858.CD006320.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2796.1989.tb01461.x","article-title":"Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial","volume":"731","author":"Lorenz","year":"1989","journal-title":"J Intern Med Suppl"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006320.pub2-BIB7|cit6","doi-asserted-by":"crossref","first-page":"1536S","DOI":"10.1093\/ajcn\/83.6.1536S","article-title":"Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions","volume":"83","author":"Akabas","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB8|cit7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003715.pub2","article-title":"Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease","author":"Akobeng","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006320.pub2-BIB9|cit8","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB10|cit9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00042737-200302000-00008","article-title":"Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial","volume":"15","author":"Bamba","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1002\/14651858.CD006320.pub2-BIB11|cit10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.clnu.2005.12.008","article-title":"CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD","volume":"25","author":"Bassaganya-Riera","year":"2006","journal-title":"Clin Nutr"},{"issue":"12","key":"10.1002\/14651858.CD006320.pub2-BIB12|cit11","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/BF02087694","article-title":"Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients","volume":"39","author":"Belluzzi","year":"1994","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1002\/14651858.CD006320.pub2-BIB13|cit12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1079\/PNS2002171","article-title":"N-3 fatty acids for the treatment of inflammatory bowel diseases","volume":"61","author":"Belluzzi","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"10.1002\/14651858.CD006320.pub2-BIB14|cit13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD006320.pub2-BIB15|cit14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/00365520410009429","article-title":"Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil","volume":"39","author":"Bjorkkjaer","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1002\/14651858.CD006320.pub2-BIB16|cit15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0197-2456(99)00026-4","article-title":"Assessing the quality of randomized trials: reliability of the Jadad scale","volume":"20","author":"Clark","year":"1999","journal-title":"Control Clin Trials"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006320.pub2-BIB17|cit16","doi-asserted-by":"crossref","first-page":"1520S","DOI":"10.1093\/ajcn\/83.6.1520S","article-title":"N-3 fatty acids and gene expression","volume":"83","author":"Deckelbaum","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10.1002\/14651858.CD006320.pub2-BIB18|cit17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1080\/00365520510015728","article-title":"Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids","volume":"40","author":"Eivindson","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"10.1002\/14651858.CD006320.pub2-BIB19|cit18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/BF02533970","article-title":"Enteral absorption in man of eicosapentaenoic acid in different chemical forms","volume":"22","author":"Boustani","year":"1987","journal-title":"Lipids"},{"issue":"5","key":"10.1002\/14651858.CD006320.pub2-BIB20|cit19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells","volume":"320","author":"Endres","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB21|cit20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00075197-199903000-00004","article-title":"Lipid treatment of inflammatory bowel disease","volume":"2","author":"Endres","year":"1999","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB22|cit21","first-page":"34","article-title":"N-3 fatty acids and the immune system in autoimmunity","volume":"4","author":"Ergas","year":"2002","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"10.1002\/14651858.CD006320.pub2-BIB23|cit22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00915822","article-title":"Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential","volume":"10","author":"Fisher","year":"1986","journal-title":"Inflammation"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB24|cit23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00054725-200005000-00002","article-title":"Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile","volume":"6","author":"Geerling","year":"2000","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB25|cit24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.1993.tb00085.x","article-title":"A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis","volume":"7","author":"Greenfield","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"issue":"8167","key":"10.1002\/14651858.CD006320.pub2-BIB26|cit25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD006320.pub2-BIB27|cit26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/gut.33.7.922","article-title":"Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial","volume":"33","author":"Hawthorne","year":"1992","journal-title":"Gut"},{"issue":"7414","key":"10.1002\/14651858.CD006320.pub2-BIB28|cit27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD006320.pub2-BIB29|cit28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/gut.32.10.1151","article-title":"Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease","volume":"32","author":"Hillier","year":"1991","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB30|cit29","article-title":"Omega 3 fatty acids for prevention and treatment of cardiovascular disease","author":"Hooper","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006320.pub2-BIB31|cit30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00005176-199105000-00005","article-title":"Development and validation of a pediatric Crohn's disease activity index","volume":"14","author":"Hyams","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB32|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"7303","key":"10.1002\/14651858.CD006320.pub2-BIB33|cit32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD006320.pub2-BIB34|cit33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD006320.pub2-BIB35|cit34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1753-4887.1996.tb03943.x","article-title":"Can fish oil maintain Crohn's disease in remission?","volume":"54","author":"Kim","journal-title":"Nutr Rev"},{"issue":"6","key":"10.1002\/14651858.CD006320.pub2-BIB36|cit35","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1018873217192","article-title":"Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease","volume":"42","author":"Kuroki","year":"1997","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB37|cit36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0006-291X(88)80718-6","article-title":"Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters","volume":"152","author":"Lawson","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"10.1002\/14651858.CD006320.pub2-BIB38|cit37","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM198505093121903","article-title":"Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function","volume":"312","author":"Lee","year":"1985","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1002\/14651858.CD006320.pub2-BIB39|cit38","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/BF02093614","article-title":"N-3 fatty acids only delay early relapse of ulcerative colitis in remission","volume":"41","author":"Loeschke","year":"1996","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1002\/14651858.CD006320.pub2-BIB40|cit39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ajcn\/82.3.611","article-title":"Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease","volume":"82","author":"MacLean","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB41|cit40","first-page":"138","article-title":"A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis","volume":"9","author":"Mantzaris","year":"1996","journal-title":"Hellenic J Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD006320.pub2-BIB42|cit41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10715760500467935","article-title":"Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages","volume":"40","author":"Marquez Martin","year":"2006","journal-title":"Free Radic Res"},{"issue":"5","key":"10.1002\/14651858.CD006320.pub2-BIB43|cit42","first-page":"A228","article-title":"Does dietary fish oil maintain the remission of Crohn's disease (CD): A case control study","volume":"100","author":"Mate","year":"1991","journal-title":"Gastroenterology"},{"issue":"47","key":"10.1002\/14651858.CD006320.pub2-BIB44|cit43","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.3748\/wjg.v11.i47.7466","article-title":"Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease","volume":"11","author":"Meister","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB45|cit44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5858\/2005-129-74-MOOICO","article-title":"Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature","volume":"129","author":"Melanson","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1002\/14651858.CD006320.pub2-BIB46|cit45","first-page":"692","article-title":"Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis","volume":"89","author":"Messori","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB47|cit46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s005350050033","article-title":"Is fish oil (n-3 fatty acids) effective for the maintenance of remission in Crohn's disease?","volume":"35","author":"Nakazawa","year":"2000","journal-title":"J Gastroenterol"},{"issue":"11-12","key":"10.1002\/14651858.CD006320.pub2-BIB48|cit47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1365-2036.2005.02698.x","article-title":"Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids","volume":"22","author":"Nielsen","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB49|cit48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jn\/132.1.11","article-title":"Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis","volume":"132","author":"Nieto","year":"2002","journal-title":"J Nutr"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB50|cit49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3122\/jabfm.18.1.28","article-title":"Practical applications of fish oil (Omega-3 fatty acids) in primary care","volume":"18","author":"Oh","year":"2005","journal-title":"J Am Board Fam Pract"},{"issue":"5","key":"10.1002\/14651858.CD006320.pub2-BIB51|cit50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-277X.2004.00552.x","article-title":"The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence","volume":"17","author":"Ruxton","journal-title":"J Hum Nutr Diet"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB52|cit51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/014860710202600298","article-title":"Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas","volume":"26","author":"Sakurai","year":"2002","journal-title":"J Parenter Enteral Nutr"},{"issue":"3","key":"10.1002\/14651858.CD006320.pub2-BIB53|cit52","first-page":"393","article-title":"Clinical and nutritional parameters in Crohn's disease patients treated with either an n-3 PUFA-enriched semi-elemental or a polymeric diet. Results of a randomized controlled trial","volume":"37","author":"Seidman","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1002\/14651858.CD006320.pub2-BIB54|cit53","first-page":"98","article-title":"Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease","volume":"30 Suppl 8","author":"Shoda","year":"1995","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB55|cit54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0026-0495(96)90194-8","article-title":"Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders","volume":"45","author":"Siguel","year":"1996","journal-title":"Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD006320.pub2-BIB56|cit55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"10.1002\/14651858.CD006320.pub2-BIB57|cit56","first-page":"413","article-title":"The influence of fish oil therapy in children with inflammatory bowel disease on the fatty acid status","volume":"4","author":"Socha","year":"2002","journal-title":"Pediatria Wspolczesna"},{"issue":"5","key":"10.1002\/14651858.CD006320.pub2-BIB58|cit57","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00365520510012136","article-title":"Essential fatty acid depletion in children with inflammatory bowel disease","volume":"40","author":"Socha","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB59|cit58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-200502000-00026","article-title":"Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease","volume":"40","author":"Thayu","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1002\/14651858.CD006320.pub2-BIB60|cit59","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ajcn\/80.5.1137","article-title":"Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease","volume":"80","author":"Trebble","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1002\/14651858.CD006320.pub2-BIB61|cit60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1079\/PNS2005419","article-title":"Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants","volume":"64","author":"Trebble","year":"2005","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"10.1002\/14651858.CD006320.pub2-BIB62|cit61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/gut.31.5.539","article-title":"Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis","volume":"31","author":"Vilaseca","year":"1990","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD006320.pub2-BIB63|cit62","article-title":"Enteral nutritional therapy for induction of remission in Crohn's disease","author":"Zachos","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006320.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T02:00:11Z","timestamp":1628733611000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006320.pub2"}},"subtitle":[],"editor":[{"given":"Dan","family":"Turner","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2007,4,18]]},"references-count":62,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006320.pub2","relation":{},"subject":[],"published":{"date-parts":[[2007,4,18]]}}}